Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Metastatic Hormone Refractory Prostate Cancer × danusertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 1 Metastatic Hormone Refractory Prostate Cancer 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia 1 Blast Crisis 1

Interventions

danusertib 1 cabozantinib 1 Prednisone 1 Nivolumab 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00766324 2014-05-28

PHA-739358 for Treatment of Hormone Refractory Prostate Cancer

Nerviano Medical Sciences

Phase 2 Completed

Metastatic Hormone Refractory Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡